Literature DB >> 8862395

Induction of apoptosis by calmodulin-dependent intracellular Ca2+ elevation in CD4+ cells expressing gp 160 of HIV.

M Sasaki1, J Uchiyama, H Ishikawa, S Matsushita, G Kimura, K Nomoto, Y Koga.   

Abstract

Human CD4+ cell clones expressing either gp160 or gp120 of HIV-1 under the transcriptional control of an inducible promoter were used to examine the role of Ca2+ signalling in the induction of apoptosis by envelope glycoproteins. Singlecell killing with apoptosis was induced in the cells expressing gp 160 while no such apoptosis was found in the cells expressing gp 120. An increase of intracellular Ca2+ was found in the gp 160-expressing cells but not in the gp 120-expressing cells as determined by Intracellular Ca2+ imaging analysis before the appearance of DNA fragmentation. W7, a calmodulin antagonist, blocked the elevation of Ca2+ as well as the resultant DNA fragmentation, which thus implies that the calmodulin-dependent intracellular Ca2+ release system is first activated by gp 160 and thereafter apoptosis takes place. The above results thus indicate that Ca2+ signalling plays a crucial role in the apoptosis accompanying the single-cell death induced by gp 160 in CD4+ cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862395     DOI: 10.1006/viro.1996.0502

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells.

Authors:  Susan B Glantz; Carol D Cianci; Rathna Iyer; Deepti Pradhan; Kevin K W Wang; Jon S Morrow
Journal:  Biochemistry       Date:  2007-01-16       Impact factor: 3.162

2.  Apoptosis induction by the binding of the carboxyl terminus of human immunodeficiency virus type 1 gp160 to calmodulin.

Authors:  H Ishikawa; M Sasaki; S Noda; Y Koga
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

3.  Calcineurin-dependent mitochondrial disturbances in calcium-induced apoptosis of human immunodeficiency virus gp160-expressing CD4+ cells.

Authors:  Masafumi Sasaki; Kozo Miyazaki; Yasuhiro Koga; Genki Kimura; Kikuo Nomoto; Hiroki Yoshida
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Induction of cytopathic effects and apoptosis in Spodoptera frugiperda cells by the HIV-1 Env glycoprotein signal peptide.

Authors:  Chad James Michalski; Yan Li; C Yong Kang
Journal:  Virus Genes       Date:  2010-09-18       Impact factor: 2.332

5.  Point mutations in the C-terminus of HIV-1 gp160 reduce apoptosis and calmodulin binding without affecting viral replication.

Authors:  Keith J Micoli; Olga Mamaeva; Sabine C Piller; Jennifer L Barker; George Pan; Eric Hunter; Jay M McDonald
Journal:  Virology       Date:  2005-10-17       Impact factor: 3.616

6.  The vpu protein of human immunodeficiency virus type 1 plays a protective role against virus-induced apoptosis in primary CD4(+) T lymphocytes.

Authors:  Satoshi Komoto; Shoutaro Tsuji; Madiha S Ibrahim; Yong-Gang Li; Jiranan Warachit; Koki Taniguchi; Kazuyoshi Ikuta
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 7.  The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.

Authors:  Thomas S Postler; Ronald C Desrosiers
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

8.  Heart and skeletal muscle are targets of dengue virus infection.

Authors:  Doris Martha Salgado; José Miguel Eltit; Keith Mansfield; César Panqueba; Dolly Castro; Martha Rocio Vega; Kris Xhaja; Diane Schmidt; Katherine J Martin; Paul D Allen; Jairo Antonio Rodriguez; Jonathan H Dinsmore; José Rafael López; Irene Bosch
Journal:  Pediatr Infect Dis J       Date:  2010-03       Impact factor: 2.129

9.  Signaling molecules in sulfur mustard-induced cutaneous injury.

Authors:  Albert L Ruff; James F Dillman
Journal:  Eplasty       Date:  2007-11-27

10.  Role of mitochondria in parvovirus pathology.

Authors:  Jonna Nykky; Matti Vuento; Leona Gilbert
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.